SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-113162
Filing Date
2022-04-21
Accepted
2022-04-21 17:04:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d279615ddefa14a.htm DEFA14A 12707
2 GRAPHIC g279615dsp018.jpg GRAPHIC 273231
3 GRAPHIC g279615dsp019.jpg GRAPHIC 176040
  Complete submission text file 0001193125-22-113162.txt   632815
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36274 | Film No.: 22842218
SIC: 2834 Pharmaceutical Preparations